A simple and highly sensitive electrochemical platform for detection of microRNAs by Jolly, Pawan et al.
        
Citation for published version:
Jolly, P, Wong, LCC, Miodek, A, Lindsay, M & Estrela, P 2015, A simple and highly sensitive electrochemical
platform for detection of microRNAs. in Proceedings of IEEE Sensors 2015. IEEE, pp. 803-806, 2015 IEEE
Sensors, Busan, Korea, Republic of, 1/11/15. https://doi.org/10.1109/ICSENS.2015.7370378
DOI:
10.1109/ICSENS.2015.7370378
Publication date:
2015
Document Version
Early version, also known as pre-print
Link to publication
© 2015 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other
users, including reprinting/ republishing this material for advertising or promotional purposes, creating new
collective works for resale or redistribution to servers or lists, or reuse of any copyrighted components of this
work in other works.
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
A Simple and Highly Sensitive Electrochemical 
Platform for Detection of MicroRNAs 
Pawan Jolly1, L.C. Caleb Wong1, Anna Miodek1, Mark A. Lindsay2, Pedro Estrela1 
1 Department of Electronic and Electrical Engineering, University of Bath, Bath, United Kingdom 
2 Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom 
Emails: p.jolly@bath.ac.uk, l.c.c.wong@bath.ac.uk, a.miodek@bath.ac.uk, m.a.lindsay@bath.ac.uk, p.estrela@bath.ac.uk 
 
 
Abstract — MicroRNAs (miRNAs) in blood can act as 
fingerprints to many diseases including cancer. However, 
detection of low levels of these miRNAs in blood demands for 
very sensitive techniques. Despite many reports available for 
miRNA detection, the available methodologies have drawbacks 
such as complexity, use of expensive enzymes, etc. We here report 
a new and simple electrochemical method to detect miRNAs by 
exploiting the intrinsic charges of the oligonucleotides and a 
simple amplification method with positively charged gold 
nanoparticles (AuNPs). Electrochemical impedance spectroscopy 
(EIS) was used to monitor the changes in capacitance upon 
miRNA binding without the need for redox markers. miRNA 
detection was also obtained through measurements of open 
circuit potential (OCP) variations. We demonstrate a promising 
cost effective biosensor using both EIS and OCP with a detection 
limit of 1 fM, which can easily be expanded into miRNA/DNA 
microarray platforms. 
Keywords — Biosensor; miRNA; Electrochemical; Gold 
nanoparticles; Prostate cancer 
I. INTRODUCTION  
MicroRNAs (miRNAs) are small non-coding RNA around 
22 nucleotides long that are involved in the gene regulation of 
the human body [1]. They have been reported to be linked 
with numerous diseases including cancer, making them 
potential biomarkers [2]. However, in order to get information 
from these miRNAs, it is important to detect the expression 
levels. Altered expression levels of these miRNAs can act as 
fingerprints and provide information about the state of cancer 
along with its progression [1,2]. Northern blotting [3] and in 
situ hybridization [4] remain the standard detection 
techniques, but these are laborious and lack sensitivity which 
has led to the development of more powerful techniques such 
as microarray technology [5] and quantitative polymerase 
chain reaction (qPCR) [6]. These techniques, although 
powerful, are still confined to central laboratories because of 
their complexity. Hence, there is a pressing need for the 
development of simpler techniques to quantify the levels of 
miRNA in a portable or benchtop system.  
On similar grounds, electrochemical techniques are 
gaining significant attention because of easy instrumentation 
and robustness along with being cost effective and sensitive 
[7]. There are various electrochemical detection techniques 
that have been reported in the literature involving e.g. 
nanoparticles [8] or enzymes [9,10] for the detection of 
miRNAs. These techniques have significantly improved the 
state of art in electrochemical miRNA detection. However, 
they still require further optimization.  
In this study, the development of a new simple and 
sensitive electrochemical detection of miRNA and DNA is 
presented. We have exploited the inherent charges of 
oligonucleotides along with a simple amplification step with 
positively charged gold nanoparticles (AuNPs). Peptide 
nucleic acids (PNA) probes have been employed as they have 
advantages such as neutral charge and higher stability than 
DNA probes. More importantly a PNA/miRNA or PNA/DNA 
duplex with mismatches are less stable than a DNA/miRNA or 
DNA/DNA duplex [11,12,13]. Electrochemical Impedance 
Spectroscopy (EIS) has been used as the detection technique 
without the use of any redox markers, thus eliminating issues 
related to the stability of redox markers.  
The key aspect of the system is its simplicity, where we 
monitor the changes in the dielectric properties of the bilayer 
close to the electrode surface. We also introduce positively 
charged AuNPs as a simple amplification strategy to disrupt 
the biolayer once it recognizes the PNA/miRNA or PNA/DNA 
duplex. With the current setup, changes in the capacitance of 
the system are observed. Furthermore, for the proof of 
concept, a DNA sequence was used for easy handling and a 
detection limit of 1 fM was achieved. We also report another 
simple detection technique based on the measurement of 
variations of the open circuit potential (OCP) by employing an 
ultra-low input bias current instrumentation amplifier circuit, 
which enables to monitor in real time variations in the 
interfacial potential.  
II. MATERIALS AND METHODS 
A. Apparatus 
The electrochemical measurements were performed using a 
CompactStat potentiostat (Ivium Technologies, The 
Netherlands) with a three-electrode cell setup with a 
Hg/Hg2SO4 (K2SO4) reference electrode (BASi, USA) 
connected via a salt bridge filled with 10 mM phosphate buffer 
(PB, pH 7.4) and a Pt counter electrode (ALS, Japan). The 
impedance spectrum was measured in 10 mM PB (pH 7.4) 
measurement buffer in a frequency range from 100 kHz to 
100 mHz, with a 10 mV a.c. voltage superimposed on a bias 
d.c. voltage of 0 V with respect to the open circuit potential.  
B. Biosensor Fabrication 
Gold working electrodes with a diameter of 2.0 mm (CH 
Instruments, USA) were cleaned using a protocol adapted from 
Keighley et al [14]: electrodes were first mechanically polished 
for 2 minutes with 1 µm diamond solution (Buehler, IL, USA) 
and thereafter for 5 minutes with 50 nm alumina slurry 
(Buehler) on respective polishing pads (Buehler). In between 
each step, 10 minutes sonication and rinsing in Milli-Q water 
was performed to remove any remaining particle residues. 
Additionally, electrodes were then exposed to chemical 
cleaning using piranha solution (3 parts of concentrated H2SO4 
with 1 part of H2O2) for 10 minutes. Electrodes were then 
rinsed with ultra-pure water and thereafter electrochemically 
cleaned in 0.5 M H2SO4 (Sigma Aldrich, UK) by scanning the 
potential between the oxidation and reduction of gold, −0.05 V 
and +1.1 V versus an Hg/Hg2SO4 reference electrode, for 50 
cycles until no further changes in the voltammogram were 
noticed. Finally, electrodes were washed with Milli-Q water. 
Clean gold electrodes were co-immobilized with a thiolated 
ssPNA sequence HS–(CH2)6–AEEA–AGA AGA AGA AGA 
AGA G, (Cambridge Research Biochemical, UK) and 6-
mercapto-1-hexanol (MCH, Sigma Aldrich, UK) in 50% 
dimethyl sulfoxide (DMSO, Sigma Aldrich, UK), 50% ultra-
pure water (v/v) immobilization solution for 16 h in a humidity 
chamber. An optimized ratio of 1:5 was adopted from the 
literature [15]. A high concentration of MCH was prepared in 
ethanol, which was diluted to working concentration in 
immobilization solution. After immobilization, electrodes were 
rinsed with DI water to remove any unattached thiols. In order 
to ensure complete thiol coverage of the gold surface, the 
electrodes were thereafter backfilled with 1 mM MCH for 1 
hour. Electrodes were then rinsed with ultra-pure water and 
placed in the measurement buffer for 1 h to stabilize the self-
assembled monolayer (SAM). 
The functionalized surface was then used to capture target 
miRNA or DNA sequences, which makes the surface 
negatively charged; finally, positively charged gold 
nanoparticles were used to electrostatically bind to the PNA-
miRNA or PNA-DNA double-strand (see Fig. 1). 
Preparation of positively charged AuNPs was adopted as 
reported by Kim et al [16]. Shortly, an optimized ratio of 
hydrogen tetrachloroaurate (HAuCl4, Sigma Aldrich, UK) and 
branched poly-(ethylenimine) (PEI, MW∼25 kDa, Sigma 
Aldrich, UK) was mixed overnight using vigorous stirring to 
produce AuNPs. Before experiments the AuNPs were washed 
three times using centrifugation and re-dispersion in Milli-Q 
water. 
For the binding studies, different concentrations of target 
DNA, non-complementary DNA and 4% bovine serum album 
(BSA) were used in 10 mM PB, pH 7.4. 
C. Open Circuit Potential 
Open Circuit Potential measurements were carried out 
using a custom made electronic measurement system based on 
an INA116 ultra low input bias current instrumentation 
amplifier with a cell [17]. The setup used consisted of 1.6 mm 
diameter gold disc working electrodes (ALS Ltd, Japan), a 
Hg/Hg2SO4 (K2SO4) reference electrode placed into a salt 
bridge, and a platinum wire for grounding the solution in the 
electrochemical cell. The OCP was measured in a solution of 
10 mM PB (pH 7.4). OCP measurement was recorded in real 
time and continuously until the experiment was finished. A 
maximum of three working electrodes were measured at the 
same time through three different channels simultaneously for 
the potential changes, by using a common reference electrode. 
III. RESULTS AND DISCUSSION 
A. Electrochemical Impedance Spectroscopy Measurement  
Electrochemical impedance spectroscopy (EIS) was used in 
this study to measure the changes in capacitance of the system 
at the electrode/electrolyte interface as a result of the binding 
event and attachment of positively charged AuNPs. The 
electrodes were initially stabilized in 10 mM PB (pH 7.4) 
before conducting binding experiments. After stabilization, the 
electrodes were exposed to different concentrations of 
complementary oligonucleotide prepared in 10 mM PB buffer 
(pH 7.4). In order to evaluate the capacitance of the system, a 
complex capacitance was defined as: 
 (1)  
Where C’ corresponds to the real part of the capacitance 
and C’’ corresponds to the imaginary part of the capacitance. 
Z’ and Z’’ are the real and imaginary components of the 
measured impedance, respectively, and ω=2πf is the angular 
frequency of the measurement. From the capacitance data, 
Cole-Cole capacitance plots can be obtained. With these plots, 
the diameter of the obtained semicircle corresponds the 
capacitance of the system (see Fig. 2).  
Figure 2 represents a typical Cole-Cole plot obtained with 
the fabricated biosensor. It can be seen that on hybridization 
with complementary strand, there is slight decrease in the 
capacitance denoted by the red curve. The probable reason for 
this small signal is that the PNA has a PEG linker (AEEA, 
C21H23NO6), hence the binding event happening far away from 
the surface and well above the Debye length of the system, 
leading to screening of the DNA charges. However, when 
incubated with positively charged AuNPs, (shown by blue 
 
Fig. 1. Schematic of biosensor. (a) Immobilized PNA probes. (b) Capture 
of target oligo (DNA/miRNA) and finally (c) electrostatic interaction of 
positively charged AuNPs with PNA/DNA or PNA/miRNA hybrid. 
curve), a significant increase in capacitance was observed due 
to disruption of the dielectric biolayer. The AEEA linker was 
used in order to decrease non-specific binding. 
Selectivity studies were performed using (i) just positively 
charged AuNPs on the immobilized PNA probes, (ii) 100 nM 
of non-complementary oligonucleotides and (iv) 4% Bovine 
Serum Albumin (BSA, Sigma Aldrich, UK). The results 
demonstrated less than 1% changes in capacitance of the 
system making it a potential platform for real clinical samples. 
Finally, a dose response was obtained with the current 
detection strategy where a very low detection limit of 1 fM was 
observed with the AuNP amplification system (see Fig. 3).  
B. Open Circuit potential measurements  
Open Circuit Potential measurement was used to measure 
the potential changes due to charge changes at the 
electrochemical interface upon DNA hybridization and 
attachment of positively charged AuNPs. All the working 
electrodes with a common reference electrode were immersed 
in a cell filled with 10 mM PB buffer (pH 7.4) and were 
measured simultaneously in real time (see fig 4). After the 
system reaching a stable value, the first injection of 100 nM 
complementary DNA was injected into the cell. As DNA 
hybridization occurs, the potential drops due to the attachment 
of negatively charged complementary strand DNA. A stable 
value is achieved after half an hour and a total change 
of -3.1 mV is observed. Then, positively charged AuNPs were 
injected and an increase of +14.7 mV was achieved. This is 
attributed to the attraction of the positive charges on the AuNPs 
to the negative charges on the PNA/DNA layer.  
The experiment was done without a flow cell and the OCP 
results in different concentrations are shown in figure 5. The 
potential changes upon DNA hybridization were lower than 
expected: < 5 mV for 1 µM of DNA target (the highest 
concentration tested). This is likely due to the presence of the 
long linker used for the PNA probe along with the excess of 
complementary strand DNA that is flowing in the solution, 
which hinders the potential change due to charge floating in the 
bulk solution. This possible reason also causes a higher 
potential change upon injecting AuNPs to the blank test. 
Although the current results do show that the changes due to 
attachment of AuNPs are distinguishable between blank and 
PNA/DNA, a further improvement can be made to enhance the 
measurement result. Adding an extra rinsing step after each 
injection, which can rinse away the excessive molecules, can 
help decrease the background signal. Nevertheless, there is still 
a clear difference between potential changes on blank and the 
tested concentrations of target DNA. Additionally, the 
decrease in the measurement cell volume can significantly 
decrease the time needed to get a stable signal on a binding 
event, which would be investigated in our future experiments. 
IV. CONCLUSIONS 
In the current work, a simple electrochemical biosensor 
with gold nanoparticle amplification for the detection of 
miRNA or DNA is presented. It has been presented how gold 
nanoparticles can disrupt the dielectric biolayer of the sensor, 
leading to significant changes in the capacitance of the system. 
With the current system, a limit of 1 fM concentration 
detection has been achieved. Furthermore, open circuit 
potential measurements, as another simple cost effective 
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Fig. 2. Cole-Cole plot representing capacitance of the system. Black 
curve shows the capacitance of PNA probe on the surface. Slight decrease 
in the capacitance is observed with hybridization of target oligo (red 
curve) which is significantly increased on binding with AuNPs. 
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Fig. 3. Dose response. Black bars represent changes in capacitance on 
binding with target oligo while red bars represent amplification in 
capacitance change on binding with AuNPs. 
 
Fig. 4. Real time OCP signal. Insert shows schematic design of 
instrumentation amplifier set-up for OCP measurement. 
detection tool, has been demonstrated to detect low levels of 
target oligonucleotides. The presented application can be 
extended to the detection of oligonucleotides specific for 
various other diseases. Of significant importance is that the 
detection techniques can easily be expanded into arrays for the 
parallel screening of panels of DNAs or miRNAs.  
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Fig. 5. Dose response with OCP setup. Blue bars represent binding with 
target oligo while yellow bars represent AuNPs amplification. 
